Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;24(1):27-28.
doi: 10.1016/j.jamda.2022.11.004. Epub 2022 Nov 11.

Risk of SARS-CoV-2 Infection in Nursing Home Residents According to COVID History and IgG Anti-Spike Antibody Levels

Helene Jeulin  1 , Carlos Labat  2 , Athanase Benetos  3
Affiliations

Risk of SARS-CoV-2 Infection in Nursing Home Residents According to COVID History and IgG Anti-Spike Antibody Levels

Helene Jeulin et al. J Am Med Dir Assoc. 2023 Jan.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Logistic regression of SARS-CoV-2 infection in NH residents after the third vaccination. Absence of history of prior COVID-19 was associated with a 10-fold increase in the risk of SARS-CoV-2 infection. Age also was a significant determinant of the risk of SARS-CoV-2 infection. Sex and IgG(S) levels following the third dose of COVID-19 messenger RNA vaccine BNT162b2 (BioNTech-Pfizer) were not associated with the risk of SARS-CoV-2 infection.
See this image and copyright information in PMC

References

    1. Teran R.A., Walblay K.A., Shane E.L., et al. Postvaccination SARSCoV-2 infections among skilled nursing facility residents and staff members–Chicago, Illinois, December 2020–March 2021. MMWR Morb Mortal Wkly Rep. 2021;30:632–638. - PMC - PubMed
    1. Jeulin H., Labat C., Duarte K., et al. Anti-spike IgG antibody kinetics following the second and third doses of BNT162b2 vaccine in nursing home residents. J Am Geriatr Soc. 2022;70:2552–2560. - PMC - PubMed
    1. Nordström P., Ballin M., Nordström A. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden. Lancet Infect Dis. 2022;22:781–790. - PMC - PubMed
    1. Witkowski W., Gerlo S., De Smet E., et al. Humoral and cellular responses to COVID-19 vaccination indicate the need for post-vaccination testing in frail population. Vaccines (Basel) 2022;10:260. - PMC - PubMed
    1. Meyer-Arndt L., Schwarz T., Loyal L., et al. Cutting edge: serum but not mucosal antibody responses are associated with pre-Existing SARS-CoV-2 spike cross-reactive CD4 + T cells following BNT162b2 Vaccination in the elderly. J Immunol. 2022;208:1001–1005. - PubMed

Publication types

Substances